Stephanic K Springer

Title: The Innovative Contributions of Stephanic K Springer

Introduction

Stephanic K Springer is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate sirtuins, which are proteins involved in cellular regulation and longevity.

Latest Patents

Stephanic holds a patent for "Quinolines and related analogs as sirtuin modulators." This patent describes novel sirtuin-modulating compounds and methods of use. The compounds are designed to increase the lifespan of cells and treat or prevent various diseases and disorders. These include conditions related to aging, stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and disorders that would benefit from increased mitochondrial activity. Additionally, the patent includes compositions that combine a sirtuin-modulating compound with another therapeutic agent.

Career Highlights

Stephanic K Springer is currently associated with GlaxoSmithKline LLC, where she continues to advance her research and development efforts. Her work focuses on innovative solutions that address critical health challenges.

Collaborations

Some of her notable coworkers include Chi B Vu and Jeremy S Disch, who collaborate with her on various projects within the company.

Conclusion

Stephanic K Springer exemplifies the spirit of innovation in biotechnology through her groundbreaking work on sirtuin modulators. Her contributions have the potential to significantly impact the treatment of age-related diseases and improve overall health outcomes.